Komori
Kissei Pharmaceutical (4547) · InitiativeAdvanced

Promoting the Development of Self-Directed Talent, Employee Fulfillment, Diversity and Health Management

First written in FY2024. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025 – FY20262024: 120242025: 120252026: 12026
Same theme, other companies
Human Capital Management Based on Talent Development and Internal Work Environment PoliciesA theme 106 companies write about · 1 as a headwind · 105 as a tailwind

The whole theme swung hardest in 2020: 2 of 7 companies on the "Worse" side.

77 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 106 companies compared. The sentences above are computed from all 106.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In March 2026, the company was certified as a Certified Health and Productivity Management Outstanding Organization 2026 (Large Enterprise Category), maintaining its certification for 7 consecutive years since 2020.」

    The company maintained its certification as a Certified Health and Productivity Management Outstanding Organization for 7 consecutive years. It also continued its human capital initiatives, including engagement surveys, DX talent development and support for the development of the next generation.
  2. FY2025AdvancedAnnual report

    「The Company has adopted "developing self-directed talent" as its central vision for human resources development and is working to develop creative talent capable of implementing its management strategy. … In March 2025, the Company obtained certification as a 2025 Certified Health and Productivity Management Outstanding Organisation in the large-enterprise category, marking 6 consecutive years of certification since 2020.」

    The Company implemented specific initiatives for developing self-directed talent, a dual-track personnel system, developing DX talent, DEI and health management, and received Certified Health and Productivity Management Outstanding Organisation certification for the 6th consecutive year.
  3. FY2024First statedAnnual report

    「The Company has adopted "developing self-directed talent" as its central vision, … places importance on employee engagement and measures it regularly. … It is working to support the development of the next generation by maintaining its Platinum Kurumin certification, establish a foundation enabling female employees to thrive under the Act on Promotion of Women's Participation and Advancement in the Workplace, operate a continued employment system through age 65, and provide an environment in which people with disabilities can work while demonstrating their individual abilities.」

    For human capital, the Company disclosed in detail for the first time an integrated set of initiatives covering the development of self-directed talent, engagement measurement, a dual-track personnel system, reskilling, women's advancement, employment of people with disabilities and health management.
Moved together

"Sustainable Growth as a Drug Discovery-Focused R&D Company" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Sustainable Growth as a Drug Discovery-Focused R&D Company2×
  3. 2Enhancing and Strengthening a Product Portfolio with Distinctive Features and Competitive Advantages2×
  4. 3Efficient Advancement of Clinical Trials for Development Programs and Early Approval2×
  5. 4Establishing a Competitive Advantage and Securing Sales in the Domestic Prescription Pharmaceutical Market2×
  6. 5Promoting overseas expansion and stabilizing the overseas earnings base2×
  7. 6Expanding into Global Markets Through Out-Licensing of Proprietary Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Kissei Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Promoting the Development of Self-Directed Talent, Employee Fulfillment, Diversity and Health Management | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | Komori